Polyzois Makras

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

Gaurav Goyal, Abdellatif Tazi, Ronald S. Go et al. · Blood · 2022 · 233 citations · Full text

Zoledronate for the Prevention of Bone Loss in Women Discontinuing Denosumab Treatment. A Prospective 2-Year Clinical Trial

Athanasios D. Anastasilakis, Socrates E. Papapoulos, Stergios A. Pοlyzos et al. · Journal of Bone and Mineral Research · 2019 · 150 citations · Full text

Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months

Athanasios D. Anastasilakis, Polyzois Makras, Athina Gkiomisi et al. · Osteoporosis International · 2014 · 131 citations

Bone Disease, Denosumab Treatment, Bone Health +8

Expression of microRNAs that regulate bone turnover in the serum of postmenopausal women with low bone mass and vertebral fractures

Maria P. Yavropoulou, Athanasios D. Anastasilakis, Polyzois Makras et al. · European Journal of Endocrinology · 2016 · 101 citations

Persistence, adherence, and medication-taking behavior in women with postmenopausal osteoporosis receiving denosumab in routine practice in Germany, Austria, Greece, and Belgium: 12-month results from a European non-interventional study

Peyman Hadji, Evelien Gielen, Maurille Feudjo Tepie et al. · Osteoporosis International · 2015 · 92 citations · Full text